blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4138913

EP4138913 - RAPID, POINT OF CARE DETECTION OF NEUTRALIZING ANTIBODIES AGAINST A VIRUS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.01.2023
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  29.10.2021
Most recent event   Tooltip31.07.2024Supplementary search reportpublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02139 / US
[2023/09]
Inventor(s)01 / LI, Hojun
173 Pleasant Street, Unit 402
Cambridge, MA 02139 / US
02 / CONNELLY, Guinevere
59 Prichard Ave
Somerville, MA 02144 / US
 [2023/09]
Representative(s)Zwicker, Jörk
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2023/09]
Application number, filing date21791985.106.04.2021
[2023/09]
WO2021US25852
Priority number, dateUS202063014886P24.04.2020         Original published format: US 202063014886 P
US202063060724P04.08.2020         Original published format: US 202063060724 P
[2023/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021216276
Date:28.10.2021
Language:EN
[2021/43]
Type: A1 Application with search report 
No.:EP4138913
Date:01.03.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 28.10.2021 takes the place of the publication of the European patent application.
[2023/09]
Search report(s)International search report - published on:US28.10.2021
(Supplementary) European search report - dispatched on:EP30.07.2024
ClassificationIPC:A61K39/395, C07K16/00, C12Q1/6888, G01N33/53, G01N33/533, G01N33/543
[2023/09]
CPC:
G01N33/54388 (EP,US); C07K16/18 (EP); G01N33/56983 (EP,US);
G01N33/6857 (US); C07K16/1003 (EP,US); C07K2317/622 (EP);
C07K2317/76 (EP); C07K2319/00 (EP); G01N2333/165 (EP,US);
G01N2469/20 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/09]
TitleGerman:SCHNELLER NACHWEIS NEUTRALISIERENDER ANTIKÖRPER GEGEN EIN VIRUS AM BEHANDLUNGSORT[2023/09]
English:RAPID, POINT OF CARE DETECTION OF NEUTRALIZING ANTIBODIES AGAINST A VIRUS[2023/09]
French:DÉTECTION RAPIDE AU POINT D'INTERVENTION D'ANTICORPS NEUTRALISANTS CONTRE UN VIRUS[2023/09]
Entry into regional phase24.11.2022National basic fee paid 
24.11.2022Search fee paid 
24.11.2022Designation fee(s) paid 
24.11.2022Examination fee paid 
Examination procedure24.11.2022Examination requested  [2023/09]
17.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.04.2023Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.202404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2009269734  (SUZUKI YASUO [JP], et al);
 [Y]WO2019147850  (BECTON DICKINSON CO [US]);
International search[A]WO2009139725  (MP BIOMEDICALS ASIA PACIFIC PT [SG], et al);
 [A]WO2016022071  (MP BIOMEDICALS ASIA PACIFIC PTE LTD [SG]);
 [A]WO2019012531  (RAMBAM MED TECH LTD [IL]);
 [A]WO2019032669  (ORASURE TECH INC [US]);
 [A]US2019219572  (MEHRA RAJESH K [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.